Castro, Cesar M
- Massachusetts General Hospital · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #10,024
- Program Leader
- R01 Holder
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#10,024
By linked amount among FY2023 PIs
Earliest Year Loaded
2021
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Castro, Cesar M as a PI. Multi-PI records show the full award amount for context.
- 1U01CA279858-01U01Contact PIComposing CODAs to cervical cancer screening through an integrated CRISPR and fluorescent nucleic acid approachMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$574.7Kaward amount
- 5R01CA264363-03R01Contact PIHigh throughput nanoplasmonic exosome testing (NEXT) of immunotherapies in bladder cancerMassachusetts General Hospital · Internal Medicine (investigator's affiliation)$433.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Castro, Cesar M as a PI.
FY2023 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardMassachusetts General Hospital
- 2021$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022R01 Grant Holder
- 2022Program/Center Grant Leader
- 2023$2M Cumulative Funding